Tags

Type your tag names separated by a space and hit enter

COVID-19: Pentoxifylline as a potential adjuvant treatment.
Int J Clin Pharmacol Ther. 2020 Jul; 58(7):406-407.IJ

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Letter

Language

eng

PubMed ID

32449676

Citation

Feily, Amir, et al. "COVID-19: Pentoxifylline as a Potential Adjuvant Treatment." International Journal of Clinical Pharmacology and Therapeutics, vol. 58, no. 7, 2020, pp. 406-407.
Feily A, Daneshpay K, Alighadr A. COVID-19: Pentoxifylline as a potential adjuvant treatment. Int J Clin Pharmacol Ther. 2020;58(7):406-407.
Feily, A., Daneshpay, K., & Alighadr, A. (2020). COVID-19: Pentoxifylline as a potential adjuvant treatment. International Journal of Clinical Pharmacology and Therapeutics, 58(7), 406-407. https://doi.org/10.5414/CP203782
Feily A, Daneshpay K, Alighadr A. COVID-19: Pentoxifylline as a Potential Adjuvant Treatment. Int J Clin Pharmacol Ther. 2020;58(7):406-407. PubMed PMID: 32449676.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19: Pentoxifylline as a potential adjuvant treatment. AU - Feily,Amir, AU - Daneshpay,Kian, AU - Alighadr,Arash, PY - 2020/06/26/accepted PY - 2020/5/26/pubmed PY - 2020/7/7/medline PY - 2020/5/26/entrez SP - 406 EP - 407 JF - International journal of clinical pharmacology and therapeutics JO - Int J Clin Pharmacol Ther VL - 58 IS - 7 SN - 0946-1965 UR - https://www.unboundmedicine.com/medline/citation/32449676/COVID-19:_Pentoxifylline_as_a_potential_adjuvant_treatment L2 - https://www.dustri.com/nc/journals-in-english?artId=186730 DB - PRIME DP - Unbound Medicine ER -